Background: The aim of this study was to evaluate prognostic factors for recurrence after conservative treatment of a large series of 'apparent' stage I serous borderline ovarian tumors (SBOTs).
introduction One-third of borderline ovarian tumors (BOTs) arise in patients below 40 years of age in whom the standard of care is conservative surgical management of the uterus and preservation of at least a part of one ovary to ensure subsequent fertility [1] . Recent papers suggest that the natural history and the outcomes of the two most frequent subtypes of BOTs (mucinous/MBOT and serous/SBOT) are somewhat different [2, 3] . SBOT can be associated with peritoneal implants (that are rare or exceptional in MBOT) in nearly a third of the cases; bilateral involvement occurs in one-third of SBOT (whereas such forms are very rare in MBOT, particularly intestinal subtypes) and the rate of preoperative infertility and postoperative infertility appears to be higher in SBOT [2] [3] [4] . Furthermore, specific histological patterns (whose clinical impact on the oncological prognosis is currently under discussion) can be observed in both forms: micropapillary patterns, for example, in SBOT or intraepithelial carcinoma in MBOT [2, 3, 5] . Finally, the distribution of MBOT and SBOT differs worldwide: MBOT arise more frequently in Asia, whereas SBOT occur more frequently in Western Europe and North America [6] . Such differences between the two most frequent subtypes of BOT may have an impact on the results reported between series, particularly after conservative treatment [1] . Thus, the distinction between the two subtypes is crucial in publications specifically devoted to the histology and/ or outcomes of BOT.
The use of conservative surgery increases the risk of recurrence, but several retrospective studies claim that such management has no impact on survival because most recurrences were borderline lesions with an excellent prognosis [7] . Nevertheless, although recurrence in the form of carcinoma is fortunately exceptional after conservative management, we still need to collect large series (at least 100 cases) with a long follow-up in order to have a more precise evaluation of this event. This risk of invasive disease and possibly death after conservative surgery according to the histological subtype continues to fuel debate in 2013 because, given the rarity of such relapses, it is unclear whether they can be imputable to conservative surgical management itself or to the natural history of the disease [7] . Basically, we need to know whether a conservative approach in BOT has an impact on survival.
Five series reporting >100 cases (all of them reporting between 100 and 200 cases) of conservative treatment have been published to date: three of them (from Asia) reported a large majority of MBOT [8] [9] [10] , whereas in the other two, the distribution of the two histotypes was not specified for patients treated conservatively [11, 12] . Here, we report the largest series of conservative surgical management of stage I SBOT, with centralization of the pathological review which is crucial to improving the reliability of the conclusions of clinical series devoted to BOT [1, 7] . Patients with SBOT and peritoneal implants have been excluded, because the indication for a conservative approach is still under debate [13] . In young patients with macroscopic stage I SBOT, conservative surgical management is indicated as the standard of care. The aim of the present series in this specific group, considered as having a good indication for fertility-preserving surgery, was to evaluate the results, and particularly clinical and oncological outcomes.
materials and methods patients
From July 1999 to November 2009, 119 patients treated at or referred to the Institut Gustave Roussy after conservative treatment of a stage I SBOT and with follow-up data were reviewed. A histopathological review of the ovarian tumor (and peritoneal implants in case of peritoneal recurrences) was carried out by one of the authors (PD). SBOT was defined according to the criteria of the World Health Organization [14] . The micropapillary pattern of the ovarian tumor was defined according to criteria established by Burks et al. [5] . Stromal microinvasion can be observed on the ovarian tumor and was defined as the presence of stromal invasion measuring <10 mm² [14] . Patients with mixed histological subtypes combining serous and nonserous BOT were excluded from present series. Morphological aspects of those patterns are shown in Figures 1 and 2 from the supplementary Material, available at Annals of Oncology online.
The staging system used was the 1987 FIGO classification (International Federation of Gynaecology and Obstetrics) [15] . The tumor stage recorded was based on the surgeon's description during the surgical procedure and on a review of the pathology records. All patients included in the present series had macroscopic and microscopic (if peritoneal staging surgery was carried out) stage I disease, defined as a tumor confined to one or both ovaries without macroscopic (or microscopic) peritoneal spread. When recurrence arose on the peritoneum, the type of peritoneal implants was classified as noninvasive or invasive according to the absence or presence of stromal invasion of the peritoneum, respectively [16] .
treatments
Conservative treatment was defined as uterus-preserving surgery with salvaging of at least a portion of one ovary. Thus, four types of conservative surgical procedures could be carried out: unilateral adnexectomy (UA), UA + contralateral cystectomy (UA + CC), unilateral cystectomy (UC) and bilateral cystectomy (BC). In theory, peritoneal cytology was systematically carried out, particularly if 'malignancy' was suspected (or identified) at surgery. Additional surgical procedures were occasionally carried out: biopsies of the contralateral ovary (during conservative treatment), an omentectomy and multiple peritoneal biopsies. Performing some of these surgeries depended on tumor histological features, the surgical teams who treated those patients and a diagnosis of SBOT during or after the surgical procedure. Peritoneal surgical staging was considered complete in the present paper if it included at least peritoneal cytology and random multiple peritoneal biopsies carried out during a one-or two-step (at the time of restaging surgery) procedure.
Patient follow-up included a clinical examination, blood tests (CA 125 determination) and an ultrasound examination every 3 months during the first year following the procedure, then every 6 months for 2 years and then yearly afterwards. 
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The recurrence rate, fertility outcomes and the number of pregnancies were analyzed. Two patients died in the present series: one of recurrent disease and the other of intercurrent disease. They were censored at the time of the death. The rates of recurrence-free intervals were determined using the Kaplan-Meier method. The log-rank test was used to compare the curves and to determine the P-value. The χ 2 test was used for the statistical analysis with a statistical significance considered at P < 0.05.
results patient characteristics
The median age of patients at the time of surgery was 29 (range, 14-65) years. Seven patients were older than 40 years. Fifty-nine patients were nulliparous. Thirteen patients had a history of infertility. Eight of them had undergone ovulation induction or in vitro Fertilization (IVF). In nine patients, the tumor had been diagnosed during a pregnancy. Patient characteristics and the type of procedure carried out are summarized in Table 1 . Ninety-two and 27 patients had (a) uni-or bilateral tumor(s), respectively. Conservative surgical procedures were the following: UA (n = 50), UC (n = 43), UA + CC (n = 15) and BC (n = 11). In 19 patients who had undergone UA or UC, a biopsy of the (macroscopically normal) contralateral ovary was carried out. No abnormalities were observed in the histological results of these systematic biopsies of macroscopically normal contralateral ovaries. Sixty patients had undergone peritoneal staging surgery, which included an omentectomy in 10 patients (during a one-step procedure in seven and two-step procedure in three).
Seventy-one (66%) patients had undergone laparoscopic surgery. Twenty (17%) patients had undergone a two-step surgical procedure (initial surgery followed by restaging or a complementary procedure), and 14 of them via laparoscopy.
The histological analysis of the tumor revealed a micropapillary pattern in 13 (11%) and/or stromal microinvasion in 21 patients (18%). Both patterns were found in four patients. recurrent tumors, prognostic factors for recurrence and survival
The median follow-up duration was 45 (range, 12-120) months. Thirty-eight (32%) patients had at least one recurrence. Eleven and four patients had, respectively, 2 and >2 recurrences. The first recurrence was noninvasive in all patients. The median age of patients at the time of their first recurrence was 29 years. Twenty-six patients had undergone conservative surgery for their recurrence. The second or third recurrence was invasive in two patients. The first recurrence was at least a borderline ovarian lesion in all but one patient (one patient having an isolated peritoneal noninvasive recurrence). However, peritoneal disease had also been diagnosed at relapse in 10 patients. Two had noninvasive autoimplants on the surface of the ovary. Six patients had noninvasive pelvic (tubes, uterine serosa…) and/or abdominal implants. Among 10 patients who had also undergone an omentectomy during their one-or two-step peritoneal staging procedure, four had relapsed (one of them in the peritoneum). Among five patients with stage IC disease and positive cytology, three recurred.
Two patients ( previously mentioned with progressive invasive disease) had invasive peritoneal disease:
• The first patient with a recurrence in the form of invasive disease had initially undergone a cystectomy followed by an adnexectomy and peritoneal staging procedures at the time of restaging surgery for a unilateral tumor (no micropapillary pattern or microinvasion). She had stage IA disease. She had relapsed 4 years later and had undergone a cystectomy followed by an IVF procedure because of persistent infertility. She became pregnant and a second recurrence was discovered during the pregnancy and removed at the time of the cesarean section (oophorectomy of the remaining ovary with resection of peritoneal implants). That lesion was a BOT with noninvasive implants. Eight years later she developed invasive peritoneal disease. This patient died 2 years after this last recurrence.
• The second invasive recurrence was observed in a patient who had undergone laparoscopic BCs for SBOT with a micropapillary pattern and stromal microinvasion (stage IB disease). Six months later she had undergone second-look surgery, which revealed noninvasive peritoneal implants on the omentum and peritoneum. She subsequently became pregnant. One year later (4 years after the first surgical management) she developed an ovarian recurrence with peritoneal lesions exhibiting invasive serous grade 1 carcinoma that had been treated with radical surgery ( peritoneal staging and lymphadenectomies), followed by adjuvant chemotherapy. She is currently disease-free 2 years after this last recurrence.
In addition, one death occurred in a 35-year-old patient who had developed a lung cancer.
Among prognostic factors for recurrences studied (Table 2) , only three achieved statistical significance in the univariate analysis: patient age (with a cut-off of 30 years), the type of conservative treatment (cystectomy versus adnexectomy) and the presence of (a) uni-or bilateral tumor(s). In the multivariate analysis, only patient age was a prognostic factor for recurrence. Nevertheless, the type of conservative treatment is very close to the reach the level of statistical significance in multivariate analysis (supplementary Table S1 , available at Annals of Oncology online). Patient characteristics according to the age of fertility results and pregnancy outcomes
Fifty pregnancies were observed in 33 (27%) patients. Among them, 11 patients had relapsed before their pregnancy. The median interval between treatment of SBOT and the first pregnancy was longer in patients who had undergone a cystectomy compared with an adnexectomy (48 versus 27 months). Seven infertile patients had achieved a pregnancy following ovulation induction with ovarian stimulation or an IVF procedure. Five of these patients were infertile before the treatment of their SBOT.
discussion
The results of the present series contain two important messages. The first one concerns the oncological results and safety of conservative treatment of SBOT. This series is one of the largest reported, to date, on the conservative treatment of SBOT, with details on the surgical procedures and different histological patterns of SBOT. Nearly 15 years ago, Zanetta et al. [17] reported 156 cases of conservative treatment of stage I SBOT, but they did not specify the type of conservative treatment. Furthermore, the series was published shortly after the description of micropapillary patterns, and no details were mentioned concerning the distribution of different histological patterns (micropapillary and stromal microinvasion) in that paper. Three women had an invasive ovarian recurrence and none of them died as a result of the disease [17] .
Our study is, therefore, the largest series reported, to date, on the conservative surgical management of stage I SBOT with details on histological features and treatments modalities. The recurrence rate is high (nearly one-third of patients), but fortunately the great majority of the tumors were borderline lesions with no impact on outcomes nor on survival. The great majority, but not all tumors: two patients developed an invasive recurrence (one died to the recurrence). In a recent review of the literature concerning the risk of recurrent invasive BOT, among 1500-1800 conservative surgical procedures that we collected, only 10 were reported in stage I SBOT [7] . It is impossible to determine whether such relapses could be related to the natural history of the tumor or to the conservative approach. Deaths (albeit in exceptional cases) were also reported in patients with stage I disease who had undergone radical surgery [18] . Our results, therefore, do not challenge the use of conservative surgery as the standard of care in young patients with SBOT [1] . Nevertheless, they do indicate that the risk of an invasive recurrence exists and, therefore, the risk of death (recently estimated at 0.5% after conservative surgery) [1] . A careful follow-up is, therefore, mandatory and patients should be informed of this rare risk.
The second important point concerns prognostic factors for recurrence. In the present series, ultraconservative treatment (a cystectomy) was shown to increase the risk of recurrence [1] . A meta-analysis and a large multicentre German series demonstrated that ultraconservative surgery increases the risk of recurrence [1, 12] . Nevertheless, this does not signify that an adnexectomy should be preferred over a cystectomy, because the use of this latter procedure also increases the fertility rate [19] . A recent phase III trial (the only one concerning BOT in the 'modern era') demonstrated that the use of BCs compared with a unilateral adnexectomy and a CC (in patients with bilateral BOT) increased the fertility rate without increasing the recurrence rate [19] . The preservation of the maximum volume of the healthy ovary (and follicles) should, therefore, be proposed to improve fertility results.
For the first time, the young age of patients was identified as a prognostic factor for recurrence, the only one singled out in the multivariate analysis. Nevertheless, in this young subgroup of patients, there was a trend towards a higher rate of bilateral tumors, the presence of stromal microinvasion and a more frequent use of cystectomy (supplementary Table S2 , available at Annals of Oncology online). Even if none of these factors were significantly different between the two groups of patients: < or >30 years (even though nonsignificant), if added, they could exert an impact on the recurrence rate. Finally, the common characteristic that we observed in our two cases of invasive recurrences was that both of them were observed at the time of the second or third recurrence, whereas the first recurrence was borderline in both cases. In these two cases, the first recurrence was treated conservatively. Perhaps, the conservative management of the first recurrence could be considered as unjustified in these two cases. In reply, our contention is that 26 patients in the current series had similar conservative treatment of their recurrence, which enabled 11 of them to become pregnant and this would not have been possible had they undergone radical surgery at the time of the first recurrence.
In this series (the largest reported, to date, on the conservative management of stage I SBOT), the risk of recurrence was not related to the histological subtypes of the tumor (micropapillary and stromal microinvasion) nor to the use of complete staging surgery. Invasive recurrences were very rare in stage I SBOT (thus validating this conservative approach in this context), but such a risk exists and could exceptionally compromise subsequent survival.
acknowledgements
We would like to thank Lorna Saint Ange for editing. disclosure
